Skip to content

Public FDA record

Z-1404-2022: X80 RADiant Photoelectric Therapy System

Recall record Z-1404-2022 for Xstrahl Limited. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1404-2022
Company in FDA record
Xstrahl Limited
FDA record creation date
Jul 19, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

There is a potential compatibility issue with the systems and replacement treatment applicators.

Source facts

Action
The firm sent out the recall notification on 04/27/2022 via email. The letter mentions the consignee is able to continue to use the system. The consignee is to ensure that the verification of selection of the correct applicator for the planned treatment is conducted with the consignee's procedures and radiotherapy professional practice and guidelines. They are asked to complete a response form and return it no later than 30 days.
Initiated
2022-04-27
Root cause
Finished device change control
Distribution
US Distribution FL, CA, KY
Recall number
Z-1404-2022
Recall status
Open, Classified
CDRH record ID
193856
FDA record created
2022-07-19
Recall event number
90231

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗